PubMed:26931464 / 1985-2083 JSONTXT

{"project":"PubTator4TogoVar","denotations":[{"id":"26931464_7","span":{"begin":78,"end":84},"obj":"ProteinMutation"}],"attributes":[{"id":"26931464_7_ProteinMutation","pred":"proteinmutation","subj":"26931464_7","obj":"rs34637584"}],"text":"We suggested that lovastatin is a potential disease-modifying agent for LRRK2-G2019S parkinsonism."}

{"project":"c_corpus","denotations":[{"id":"T288","span":{"begin":18,"end":28},"obj":"6472"},{"id":"T286","span":{"begin":18,"end":28},"obj":"D008148"},{"id":"T287","span":{"begin":18,"end":28},"obj":"D008148"},{"id":"T289","span":{"begin":18,"end":28},"obj":"CHEBI:40303"},{"id":"T290","span":{"begin":44,"end":51},"obj":"D004194"},{"id":"T291","span":{"begin":44,"end":51},"obj":"D004194"},{"id":"T292","span":{"begin":72,"end":77},"obj":"PR:Q5S006"},{"id":"T293","span":{"begin":72,"end":77},"obj":"PR:000003033"},{"id":"T294","span":{"begin":72,"end":77},"obj":"PR:Q5S007"},{"id":"T295","span":{"begin":85,"end":97},"obj":"D020734"},{"id":"T296","span":{"begin":85,"end":97},"obj":"D020734"}],"text":"We suggested that lovastatin is a potential disease-modifying agent for LRRK2-G2019S parkinsonism."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T15","span":{"begin":0,"end":98},"obj":"DRI_Approach"}],"text":"We suggested that lovastatin is a potential disease-modifying agent for LRRK2-G2019S parkinsonism."}